Shanghai, China ShangPharma appeared to be the Corporate Investor, which was created in 2002. The company was established in Asia in China. The leading representative office of defined Corporate Investor is situated in the Shanghai.
The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2016. Opposing the other organizations, this ShangPharma works on 4 percentage points less the average amount of lead investments. The increased amount of exits for fund were in 2019. The fund is constantly included in less than 2 investment rounds annually.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the ShangPharma, startups are often financed by Timothy A. Springer, Schrodinger, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures HC, Vertex Ventures, Timothy A. Springer. In the next rounds fund is usually obtained by Whitesun Healthcare Ventures, WI Harper Group, Timothy A. Springer.
Among the most popular portfolio startups of the fund, we may highlight Obsidian Therapeutics, Circle Pharma, Morphic Therapeutic. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biotechnology.
| Fund Name | Location |
| Alpha Technologies | Bellingham, United States, Washington |
| Apicap | France, Ile-de-France, Paris |
| Asian Gateway Investments | - |
| Blazar Ventures LLC | Alexandria, United States, Virginia |
| Capital Medica Ventures | Chiyoda, Japan |
| Fjord Ventures | California, Laguna Hills, United States |
| Foundamental | - |
| Galaxy Finance Holding Group | - |
| InnovaFonds | Corenc, France, Rhone-Alpes |
| Kun Lun Stone Capital | China, Guangdong, Shenzhen |
| Lumar | Ilford, Redbridge, United Kingdom |
| Maersk Line | Copenhagen, Denmark, Hovedstaden |
| Majid Al Futtaim Holdings LLC. | Dubai, United Arab Emirates |
| Riverhead Capital | India, Maharashtra, Mumbai |
| Tenex Medical Investors | Burlingame, California, United States |
| UNITED VENTURE CAPITAL | Japan, Tokyo |
| University Hospital Ventures | Cleveland, Ohio, United States |
| Zhongjinchuanhua (Ningbo) Industry Equity Investment Fund | China, Ningbo, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Circle Pharma | $45M | 17 Mar 2020 | San Francisco, California, United States | ||
Morphic Therapeutic | $80M | 25 Sep 2018 | Massachusetts, United States | ||
APRINOIA Therapeutics | $11M | 16 Jan 2018 | New Taipei | ||
Obsidian Therapeutics | $49M | 06 Dec 2017 | Cambridge, Massachusetts, United States | ||
Circle Pharma | $4M | 21 Dec 2016 | San Francisco, California, United States | ||
Morphic Therapeutic | $51M | 30 Jun 2016 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Circle Pharma | $45M | 17 Mar 2020 | San Francisco, California, United States | ||
Morphic Therapeutic | $80M | 25 Sep 2018 | Massachusetts, United States | ||
APRINOIA Therapeutics | $11M | 16 Jan 2018 | New Taipei | ||
Obsidian Therapeutics | $49M | 06 Dec 2017 | Cambridge, Massachusetts, United States | ||
Circle Pharma | $4M | 21 Dec 2016 | San Francisco, California, United States | ||
Morphic Therapeutic | $51M | 30 Jun 2016 | Massachusetts, United States |
